APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ophthalmic Drug Delivery System

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ophthalmic Drug Delivery System Market Outlook and Growth Opportunities 2026

4 July 2026216 pages

Choose your research edition.

Industry ResearchOphthalmic Drug Delivery System Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Ophthalmic Drug Delivery System Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Ophthalmic Drug Delivery System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ophthalmic Drug Delivery System Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Ophthalmic Drug Delivery System Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Ophthalmic Drug Delivery System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ophthalmic Drug Delivery System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ophthalmic Drug Delivery System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ophthalmic Drug Delivery System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ophthalmic Drug Delivery System market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ophthalmic Drug Delivery System market include Aero Pump GmbH, AptarGroup, Bausch Health, Becton Dickinson & Company, Biocorp Production, Clearside Biomedical, Envisia Therapeutics, EyePoint Pharmaceuticals, Inc. and Gaplast GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ophthalmic Drug Delivery System market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ophthalmic Drug Delivery System and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ophthalmic Drug Delivery System sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ophthalmic Drug Delivery System market size, projected growth trends, production technologies, key applications, and end-use industries.

Ophthalmic Drug Delivery System Segment by Company

Aero Pump GmbH

AptarGroup

Bausch Health

Becton Dickinson & Company

Biocorp Production

Clearside Biomedical

Envisia Therapeutics

EyePoint Pharmaceuticals, Inc.

Gaplast GmbH

Gerresheimer

Graybug Vision

Kedalion Therapeutics

Mati Therapeutics, Inc.,

Nemera

Nipro Corporation

Ocular Therapeutix

Ocumedic, Inc.

Owen Mumford

Re-Vana Therapeutics

Santen Pharmaceutical

Silgan Holdings Inc.

Taiwan Liposome

Terumo Corporation

West Pharmaceutical Services, Inc.

Ophthalmic Drug Delivery System Segment by Type

Implantable Ophthalmic Drug Delivery Systems

Particulate Ophthalmic Drug Delivery Systems

Others

Ophthalmic Drug Delivery System Segment by Application

Clinics

Hospitals

Ambulatory Surgical Centers

Others

Ophthalmic Drug Delivery System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Ophthalmic Drug Delivery System status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Ophthalmic Drug Delivery System market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ophthalmic Drug Delivery System significant trends, drivers, influence factors in global and regions.

6. To analyze Ophthalmic Drug Delivery System competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmic Drug Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ophthalmic Drug Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmic Drug Delivery System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ophthalmic Drug Delivery System market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ophthalmic Drug Delivery System industry.

Chapter 3: Detailed analysis of Ophthalmic Drug Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Ophthalmic Drug Delivery System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Ophthalmic Drug Delivery System in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ophthalmic Drug Delivery System Industry Trends Table 2. Ophthalmic Drug Delivery System Industry Drivers Table 3. Ophthalmic Drug Delivery System Industry Opportunities and Challenges Table 4. Ophthalmic Drug Delivery System Industry Restraints Table 5. Global Ophthalmic Drug Delivery System Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ophthalmic Drug Delivery System Revenue Share by Company (2021-2026) Table 7. Global Ophthalmic Drug Delivery System Sales Volume by Company (k units) & (2021-2026) Table 8. Global Ophthalmic Drug Delivery System Sales Volume Share by Company (2021-2026) Table 9. Global Ophthalmic Drug Delivery System Average Price (USD/unit) of Company (2021-2026) Table 10. Global Ophthalmic Drug Delivery System Company Ranking, (2024-2026) & (USD Million) Table 11. Global Ophthalmic Drug Delivery System Key Company Manufacturing Base & Headquarters Table 12. Global Ophthalmic Drug Delivery System Company, Product Type & Application Table 13. Global Ophthalmic Drug Delivery System Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Ophthalmic Drug Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Implantable Ophthalmic Drug Delivery Systems Table 18. Significant Companies of Particulate Ophthalmic Drug Delivery Systems Table 19. Significant Companies of Others Table 20. Global Ophthalmic Drug Delivery System Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Ophthalmic Drug Delivery System Sales Volume by Type (2021-2026) & (k units) Table 22. Global Ophthalmic Drug Delivery System Sales Volume by Type (2027-2032) & (k units) Table 23. Global Ophthalmic Drug Delivery System Sales Volume Share by Type (2021-2026) Table 24. Global Ophthalmic Drug Delivery System Sales Volume Share by Type (2027-2032) Table 25. Global Ophthalmic Drug Delivery System Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Ophthalmic Drug Delivery System Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Ophthalmic Drug Delivery System Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Ophthalmic Drug Delivery System Sales Value Share by Type (2021-2026) Table 29. Global Ophthalmic Drug Delivery System Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Clinics Table 31. Significant Companies of Hospitals Table 32. Significant Companies of Ambulatory Surgical Centers Table 33. Significant Companies of Others Table 34. Global Ophthalmic Drug Delivery System Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Ophthalmic Drug Delivery System Sales Volume by Application (2021-2026) & (k units) Table 36. Global Ophthalmic Drug Delivery System Sales Volume by Application (2027-2032) & (k units) Table 37. Global Ophthalmic Drug Delivery System Sales Volume Share by Application (2021-2026) Table 38. Global Ophthalmic Drug Delivery System Sales Volume Share by Application (2027-2032) Table 39. Global Ophthalmic Drug Delivery System Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Ophthalmic Drug Delivery System Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Ophthalmic Drug Delivery System Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Ophthalmic Drug Delivery System Sales Value Share by Application (2021-2026) Table 43. Global Ophthalmic Drug Delivery System Sales Value Share by Application (2027-2032) Table 44. Global Ophthalmic Drug Delivery System Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Ophthalmic Drug Delivery System Sales by Region (2021-2026) & (k units) Table 46. Global Ophthalmic Drug Delivery System Sales Market Share by Region (2021-2026) Table 47. Global Ophthalmic Drug Delivery System Sales by Region (2027-2032) & (k units) Table 48. Global Ophthalmic Drug Delivery System Sales Market Share by Region (2027-2032) Table 49. Global Ophthalmic Drug Delivery System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Ophthalmic Drug Delivery System Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Ophthalmic Drug Delivery System Sales Value Share by Region (2021-2026) Table 52. Global Ophthalmic Drug Delivery System Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Ophthalmic Drug Delivery System Sales Value Share by Region (2027-2032) Table 54. Global Ophthalmic Drug Delivery System Market Average Price (USD/unit) by Region (2021-2026) Table 55. Global Ophthalmic Drug Delivery System Market Average Price (USD/unit) by Region (2027-2032) Table 56. Global Ophthalmic Drug Delivery System Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Ophthalmic Drug Delivery System Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Ophthalmic Drug Delivery System Sales by Country (2021-2026) & (k units) Table 59. Global Ophthalmic Drug Delivery System Sales Market Share by Country (2021-2026) Table 60. Global Ophthalmic Drug Delivery System Sales by Country (2027-2032) & (k units) Table 61. Global Ophthalmic Drug Delivery System Sales Market Share by Country (2027-2032) Table 62. Global Ophthalmic Drug Delivery System Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Ophthalmic Drug Delivery System Sales Value Market Share by Country (2021-2026) Table 64. Global Ophthalmic Drug Delivery System Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Ophthalmic Drug Delivery System Sales Value Market Share by Country (2027-2032) Table 66. Aero Pump GmbH Company Information Table 67. Aero Pump GmbH Business Overview Table 68. Aero Pump GmbH Ophthalmic Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 69. Aero Pump GmbH Ophthalmic Drug Delivery System Product Portfolio Table 70. Aero Pump GmbH Recent Development Table 71. AptarGroup Company Information Table 72. AptarGroup Business Overview Table 73. AptarGroup Ophthalmic Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. AptarGroup Ophthalmic Drug Delivery System Product Portfolio Table 75. AptarGroup Recent Development Table 76. Bausch Health Company Information Table 77. Bausch Health Business Overview Table 78. Bausch Health Ophthalmic Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Bausch Health Ophthalmic Drug Delivery System Product Portfolio Table 80. Bausch Health Recent Development Table 81. Becton Dickinson & Company Company Information Table 82. Becton Dickinson & Company Business Overview Table 83. Becton Dickinson & Company Ophthalmic Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Becton Dickinson & Company Ophthalmic Drug Delivery System Product Portfolio Table 85. Becton Dickinson & Company Recent Development Table 86. Biocorp Production Company Information Table 87. Biocorp Production Business Overview Table 88. Biocorp Production Ophthalmic Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Biocorp Production Ophthalmic Drug Delivery System Product Portfolio Table 90. Biocorp Production Recent Development Table 91. Clearside Biomedical Company Information Table 92. Clearside Biomedical Business Overview Table 93. Clearside Biomedical Ophthalmic Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Clearside Biomedical Ophthalmic Drug Delivery System Product Portfolio Table 95. Clearside Biomedical Recent Development Table 96. Envisia Therapeutics Company Information Table 97. Envisia Therapeutics Business Overview Table 98. Envisia Therapeutics Ophthalmic Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Envisia Therapeutics Ophthalmic Drug Delivery System Product Portfolio Table 100. Envisia Therapeutics Recent Development Table 101. EyePoint Pharmaceuticals, Inc. Company Information Table 102. EyePoint Pharmaceuticals, Inc. Business Overview Table 103. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Product Portfolio Table 105. EyePoint Pharmaceuticals, Inc. Recent Development Table 106. Gaplast GmbH Company Information Table 107. Gaplast GmbH Business Overview Table 108. Gaplast GmbH Ophthalmic Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Gaplast GmbH Ophthalmic Drug Delivery System Product Portfolio Table 110. Gaplast GmbH Recent Development Table 111. Gerresheimer Company Information Table 112. Gerresheimer Business Overview Table 113. Gerresheimer Ophthalmic Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Gerresheimer Ophthalmic Drug Delivery System Product Portfolio Table 115. Gerresheimer Recent Development Table 116. Graybug Vision Company Information Table 117. Graybug Vision Business Overview Table 118. Graybug Vision Ophthalmic Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Graybug Vision Ophthalmic Drug Delivery System Product Portfolio Table 120. Graybug Vision Recent Development Table 121. Kedalion Therapeutics Company Information Table 122. Kedalion Therapeutics Business Overview Table 123. Kedalion Therapeutics Ophthalmic Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Kedalion Therapeutics Ophthalmic Drug Delivery System Product Portfolio Table 125. Kedalion Therapeutics Recent Development Table 126. Mati Therapeutics, Inc., Company Information Table 127. Mati Therapeutics, Inc., Business Overview Table 128. Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Product Portfolio Table 130. Mati Therapeutics, Inc., Recent Development Table 131. Nemera Company Information Table 132. Nemera Business Overview Table 133. Nemera Ophthalmic Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Nemera Ophthalmic Drug Delivery System Product Portfolio Table 135. Nemera Recent Development Table 136. Nipro Corporation Company Information Table 137. Nipro Corporation Business Overview Table 138. Nipro Corporation Ophthalmic Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Nipro Corporation Ophthalmic Drug Delivery System Product Portfolio Table 140. Nipro Corporation Recent Development Table 141. Ocular Therapeutix Company Information Table 142. Ocular Therapeutix Business Overview Table 143. Ocular Therapeutix Ophthalmic Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Ocular Therapeutix Ophthalmic Drug Delivery System Product Portfolio Table 145. Ocular Therapeutix Recent Development Table 146. Ocumedic, Inc. Company Information Table 147. Ocumedic, Inc. Business Overview Table 148. Ocumedic, Inc. Ophthalmic Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Ocumedic, Inc. Ophthalmic Drug Delivery System Product Portfolio Table 150. Ocumedic, Inc. Recent Development Table 151. Owen Mumford Company Information Table 152. Owen Mumford Business Overview Table 153. Owen Mumford Ophthalmic Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. Owen Mumford Ophthalmic Drug Delivery System Product Portfolio Table 155. Owen Mumford Recent Development Table 156. Re-Vana Therapeutics Company Information Table 157. Re-Vana Therapeutics Business Overview Table 158. Re-Vana Therapeutics Ophthalmic Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. Re-Vana Therapeutics Ophthalmic Drug Delivery System Product Portfolio Table 160. Re-Vana Therapeutics Recent Development Table 161. Santen Pharmaceutical Company Information Table 162. Santen Pharmaceutical Business Overview Table 163. Santen Pharmaceutical Ophthalmic Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 164. Santen Pharmaceutical Ophthalmic Drug Delivery System Product Portfolio Table 165. Santen Pharmaceutical Recent Development Table 166. Silgan Holdings Inc. Company Information Table 167. Silgan Holdings Inc. Business Overview Table 168. Silgan Holdings Inc. Ophthalmic Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 169. Silgan Holdings Inc. Ophthalmic Drug Delivery System Product Portfolio Table 170. Silgan Holdings Inc. Recent Development Table 171. Taiwan Liposome Company Information Table 172. Taiwan Liposome Business Overview Table 173. Taiwan Liposome Ophthalmic Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 174. Taiwan Liposome Ophthalmic Drug Delivery System Product Portfolio Table 175. Taiwan Liposome Recent Development Table 176. Terumo Corporation Company Information Table 177. Terumo Corporation Business Overview Table 178. Terumo Corporation Ophthalmic Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 179. Terumo Corporation Ophthalmic Drug Delivery System Product Portfolio Table 180. Terumo Corporation Recent Development Table 181. West Pharmaceutical Services, Inc. Company Information Table 182. West Pharmaceutical Services, Inc. Business Overview Table 183. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 184. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Product Portfolio Table 185. West Pharmaceutical Services, Inc. Recent Development Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Ophthalmic Drug Delivery System Distributors List Table 189. Ophthalmic Drug Delivery System Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Ophthalmic Drug Delivery System Product Image Figure 2. Global Ophthalmic Drug Delivery System Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ophthalmic Drug Delivery System Sales Value (2021-2032) & (US$ Million) Figure 4. Global Ophthalmic Drug Delivery System Sales (2021-2032) & (k units) Figure 5. Global Ophthalmic Drug Delivery System Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Ophthalmic Drug Delivery System Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Implantable Ophthalmic Drug Delivery Systems Image Figure 10. Particulate Ophthalmic Drug Delivery Systems Image Figure 11. Others Image Figure 12. Global Ophthalmic Drug Delivery System Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Ophthalmic Drug Delivery System Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Ophthalmic Drug Delivery System Sales Volume Share by Type (2021-2032) Figure 15. Global Ophthalmic Drug Delivery System Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Ophthalmic Drug Delivery System Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Ophthalmic Drug Delivery System Sales Value Share by Type (2021-2032) Figure 18. Clinics Image Figure 19. Hospitals Image Figure 20. Ambulatory Surgical Centers Image Figure 21. Others Image Figure 22. Global Ophthalmic Drug Delivery System Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Ophthalmic Drug Delivery System Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Ophthalmic Drug Delivery System Sales Volume Share by Application (2021-2032) Figure 25. Global Ophthalmic Drug Delivery System Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Ophthalmic Drug Delivery System Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Ophthalmic Drug Delivery System Sales Value Share by Application (2021-2032) Figure 28. Global Ophthalmic Drug Delivery System Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Ophthalmic Drug Delivery System Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Ophthalmic Drug Delivery System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Ophthalmic Drug Delivery System Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Ophthalmic Drug Delivery System Sales Value (2021-2032) & (US$ Million) Figure 33. North America Ophthalmic Drug Delivery System Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Ophthalmic Drug Delivery System Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Ophthalmic Drug Delivery System Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Ophthalmic Drug Delivery System Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Ophthalmic Drug Delivery System Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Ophthalmic Drug Delivery System Sales Value (2021-2032) & (US$ Million) Figure 39. South America Ophthalmic Drug Delivery System Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Ophthalmic Drug Delivery System Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Ophthalmic Drug Delivery System Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Ophthalmic Drug Delivery System Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Ophthalmic Drug Delivery System Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Implantable Ophthalmic Drug Delivery Systems
  • Particulate Ophthalmic Drug Delivery Systems
  • Others
Applications
  • Clinics
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
Companies covered
  • Aero Pump GmbH
  • AptarGroup
  • Bausch Health
  • Becton Dickinson & Company
  • Biocorp Production
  • Clearside Biomedical
  • Envisia Therapeutics
  • EyePoint Pharmaceuticals, Inc.
  • Gaplast GmbH
  • Gerresheimer
  • Graybug Vision
  • Kedalion Therapeutics
  • Mati Therapeutics, Inc.,
  • Nemera
  • Nipro Corporation
  • Ocular Therapeutix
  • Ocumedic, Inc.
  • Owen Mumford
  • Re-Vana Therapeutics
  • Santen Pharmaceutical
  • Silgan Holdings Inc.
  • Taiwan Liposome
  • Terumo Corporation
  • West Pharmaceutical Services, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ophthalmic Drug Delivery System Sales Value (2021-2032)
  4. 1.2.2 Global Ophthalmic Drug Delivery System Sales Volume (2021-2032)
  5. 1.2.3 Global Ophthalmic Drug Delivery System Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Ophthalmic Drug Delivery System Market Dynamics
  1. 2.1 Ophthalmic Drug Delivery System Industry Trends
  2. 2.2 Ophthalmic Drug Delivery System Industry Drivers
  3. 2.3 Ophthalmic Drug Delivery System Industry Opportunities and Challenges
  4. 2.4 Ophthalmic Drug Delivery System Industry Restraints
3 Ophthalmic Drug Delivery System Market by Company
  1. 3.1 Global Ophthalmic Drug Delivery System Company Revenue Ranking in 2025
  2. 3.2 Global Ophthalmic Drug Delivery System Revenue by Company (2021-2026)
  3. 3.3 Global Ophthalmic Drug Delivery System Sales Volume by Company (2021-2026)
  4. 3.4 Global Ophthalmic Drug Delivery System Average Price by Company (2021-2026)
  5. 3.5 Global Ophthalmic Drug Delivery System Company Ranking (2024-2026)
  6. 3.6 Global Ophthalmic Drug Delivery System Company Manufacturing Base and Headquarters
  7. 3.7 Global Ophthalmic Drug Delivery System Company Product Type and Application
  8. 3.8 Global Ophthalmic Drug Delivery System Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Ophthalmic Drug Delivery System Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Ophthalmic Drug Delivery System Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Ophthalmic Drug Delivery System Market by Type
  1. 4.1 Ophthalmic Drug Delivery System Type Introduction
  2. 4.1.1 Implantable Ophthalmic Drug Delivery Systems
  3. 4.1.2 Particulate Ophthalmic Drug Delivery Systems
  4. 4.1.3 Others
  5. 4.2 Global Ophthalmic Drug Delivery System Sales Volume by Type
  6. 4.2.1 Global Ophthalmic Drug Delivery System Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Ophthalmic Drug Delivery System Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Ophthalmic Drug Delivery System Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Ophthalmic Drug Delivery System Sales Value by Type
  10. 4.3.1 Global Ophthalmic Drug Delivery System Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Ophthalmic Drug Delivery System Sales Value by Type (2021-2032)
  12. 4.3.3 Global Ophthalmic Drug Delivery System Sales Value Share by Type (2021-2032)
5 Ophthalmic Drug Delivery System Market by Application
  1. 5.1 Ophthalmic Drug Delivery System Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Ambulatory Surgical Centers
  5. 5.1.4 Others
  6. 5.2 Global Ophthalmic Drug Delivery System Sales Volume by Application
  7. 5.2.1 Global Ophthalmic Drug Delivery System Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Ophthalmic Drug Delivery System Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Ophthalmic Drug Delivery System Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Ophthalmic Drug Delivery System Sales Value by Application
  11. 5.3.1 Global Ophthalmic Drug Delivery System Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Ophthalmic Drug Delivery System Sales Value by Application (2021-2032)
  13. 5.3.3 Global Ophthalmic Drug Delivery System Sales Value Share by Application (2021-2032)
6 Ophthalmic Drug Delivery System Regional Sales and Value Analysis
  1. 6.1 Global Ophthalmic Drug Delivery System Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ophthalmic Drug Delivery System Sales by Region (2021-2032)
  3. 6.2.1 Global Ophthalmic Drug Delivery System Sales by Region: 2021-2026
  4. 6.2.2 Global Ophthalmic Drug Delivery System Sales by Region (2027-2032)
  5. 6.3 Global Ophthalmic Drug Delivery System Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Ophthalmic Drug Delivery System Sales Value by Region (2021-2032)
  7. 6.4.1 Global Ophthalmic Drug Delivery System Sales Value by Region: 2021-2026
  8. 6.4.2 Global Ophthalmic Drug Delivery System Sales Value by Region (2027-2032)
  9. 6.5 Global Ophthalmic Drug Delivery System Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Ophthalmic Drug Delivery System Sales Value (2021-2032)
  12. 6.6.2 North America Ophthalmic Drug Delivery System Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Ophthalmic Drug Delivery System Sales Value (2021-2032)
  15. 6.7.2 Europe Ophthalmic Drug Delivery System Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Ophthalmic Drug Delivery System Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Ophthalmic Drug Delivery System Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Ophthalmic Drug Delivery System Sales Value (2021-2032)
  21. 6.9.2 South America Ophthalmic Drug Delivery System Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Ophthalmic Drug Delivery System Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Ophthalmic Drug Delivery System Sales Value Share by Country, 2025 VS 2032
7 Ophthalmic Drug Delivery System Country-level Sales and Value Analysis
  1. 7.1 Global Ophthalmic Drug Delivery System Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ophthalmic Drug Delivery System Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Ophthalmic Drug Delivery System Sales by Country (2021-2032)
  4. 7.3.1 Global Ophthalmic Drug Delivery System Sales by Country (2021-2026)
  5. 7.3.2 Global Ophthalmic Drug Delivery System Sales by Country (2027-2032)
  6. 7.4 Global Ophthalmic Drug Delivery System Sales Value by Country (2021-2032)
  7. 7.4.1 Global Ophthalmic Drug Delivery System Sales Value by Country (2021-2026)
  8. 7.4.2 Global Ophthalmic Drug Delivery System Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Ophthalmic Drug Delivery System Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Ophthalmic Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Ophthalmic Drug Delivery System Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Aero Pump GmbH
  2. 8.1.1 Aero Pump GmbH Company Information
  3. 8.1.2 Aero Pump GmbH Business Overview
  4. 8.1.3 Aero Pump GmbH Ophthalmic Drug Delivery System Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Aero Pump GmbH Ophthalmic Drug Delivery System Product Portfolio
  6. 8.1.5 Aero Pump GmbH Recent Developments
  7. 8.2 AptarGroup
  8. 8.2.1 AptarGroup Company Information
  9. 8.2.2 AptarGroup Business Overview
  10. 8.2.3 AptarGroup Ophthalmic Drug Delivery System Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 AptarGroup Ophthalmic Drug Delivery System Product Portfolio
  12. 8.2.5 AptarGroup Recent Developments
  13. 8.3 Bausch Health
  14. 8.3.1 Bausch Health Company Information
  15. 8.3.2 Bausch Health Business Overview
  16. 8.3.3 Bausch Health Ophthalmic Drug Delivery System Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bausch Health Ophthalmic Drug Delivery System Product Portfolio
  18. 8.3.5 Bausch Health Recent Developments
  19. 8.4 Becton Dickinson & Company
  20. 8.4.1 Becton Dickinson & Company Company Information
  21. 8.4.2 Becton Dickinson & Company Business Overview
  22. 8.4.3 Becton Dickinson & Company Ophthalmic Drug Delivery System Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Becton Dickinson & Company Ophthalmic Drug Delivery System Product Portfolio
  24. 8.4.5 Becton Dickinson & Company Recent Developments
  25. 8.5 Biocorp Production
  26. 8.5.1 Biocorp Production Company Information
  27. 8.5.2 Biocorp Production Business Overview
  28. 8.5.3 Biocorp Production Ophthalmic Drug Delivery System Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Biocorp Production Ophthalmic Drug Delivery System Product Portfolio
  30. 8.5.5 Biocorp Production Recent Developments
  31. 8.6 Clearside Biomedical
  32. 8.6.1 Clearside Biomedical Company Information
  33. 8.6.2 Clearside Biomedical Business Overview
  34. 8.6.3 Clearside Biomedical Ophthalmic Drug Delivery System Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Clearside Biomedical Ophthalmic Drug Delivery System Product Portfolio
  36. 8.6.5 Clearside Biomedical Recent Developments
  37. 8.7 Envisia Therapeutics
  38. 8.7.1 Envisia Therapeutics Company Information
  39. 8.7.2 Envisia Therapeutics Business Overview
  40. 8.7.3 Envisia Therapeutics Ophthalmic Drug Delivery System Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Envisia Therapeutics Ophthalmic Drug Delivery System Product Portfolio
  42. 8.7.5 Envisia Therapeutics Recent Developments
  43. 8.8 EyePoint Pharmaceuticals, Inc.
  44. 8.8.1 EyePoint Pharmaceuticals, Inc. Company Information
  45. 8.8.2 EyePoint Pharmaceuticals, Inc. Business Overview
  46. 8.8.3 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Product Portfolio
  48. 8.8.5 EyePoint Pharmaceuticals, Inc. Recent Developments
  49. 8.9 Gaplast GmbH
  50. 8.9.1 Gaplast GmbH Company Information
  51. 8.9.2 Gaplast GmbH Business Overview
  52. 8.9.3 Gaplast GmbH Ophthalmic Drug Delivery System Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Gaplast GmbH Ophthalmic Drug Delivery System Product Portfolio
  54. 8.9.5 Gaplast GmbH Recent Developments
  55. 8.10 Gerresheimer
  56. 8.10.1 Gerresheimer Company Information
  57. 8.10.2 Gerresheimer Business Overview
  58. 8.10.3 Gerresheimer Ophthalmic Drug Delivery System Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Gerresheimer Ophthalmic Drug Delivery System Product Portfolio
  60. 8.10.5 Gerresheimer Recent Developments
  61. 8.11 Graybug Vision
  62. 8.11.1 Graybug Vision Company Information
  63. 8.11.2 Graybug Vision Business Overview
  64. 8.11.3 Graybug Vision Ophthalmic Drug Delivery System Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Graybug Vision Ophthalmic Drug Delivery System Product Portfolio
  66. 8.11.5 Graybug Vision Recent Developments
  67. 8.12 Kedalion Therapeutics
  68. 8.12.1 Kedalion Therapeutics Company Information
  69. 8.12.2 Kedalion Therapeutics Business Overview
  70. 8.12.3 Kedalion Therapeutics Ophthalmic Drug Delivery System Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Kedalion Therapeutics Ophthalmic Drug Delivery System Product Portfolio
  72. 8.12.5 Kedalion Therapeutics Recent Developments
  73. 8.13 Mati Therapeutics, Inc.,
  74. 8.13.1 Mati Therapeutics, Inc., Company Information
  75. 8.13.2 Mati Therapeutics, Inc., Business Overview
  76. 8.13.3 Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Product Portfolio
  78. 8.13.5 Mati Therapeutics, Inc., Recent Developments
  79. 8.14 Nemera
  80. 8.14.1 Nemera Company Information
  81. 8.14.2 Nemera Business Overview
  82. 8.14.3 Nemera Ophthalmic Drug Delivery System Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Nemera Ophthalmic Drug Delivery System Product Portfolio
  84. 8.14.5 Nemera Recent Developments
  85. 8.15 Nipro Corporation
  86. 8.15.1 Nipro Corporation Company Information
  87. 8.15.2 Nipro Corporation Business Overview
  88. 8.15.3 Nipro Corporation Ophthalmic Drug Delivery System Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Nipro Corporation Ophthalmic Drug Delivery System Product Portfolio
  90. 8.15.5 Nipro Corporation Recent Developments
  91. 8.16 Ocular Therapeutix
  92. 8.16.1 Ocular Therapeutix Company Information
  93. 8.16.2 Ocular Therapeutix Business Overview
  94. 8.16.3 Ocular Therapeutix Ophthalmic Drug Delivery System Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Ocular Therapeutix Ophthalmic Drug Delivery System Product Portfolio
  96. 8.16.5 Ocular Therapeutix Recent Developments
  97. 8.17 Ocumedic, Inc.
  98. 8.17.1 Ocumedic, Inc. Company Information
  99. 8.17.2 Ocumedic, Inc. Business Overview
  100. 8.17.3 Ocumedic, Inc. Ophthalmic Drug Delivery System Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Ocumedic, Inc. Ophthalmic Drug Delivery System Product Portfolio
  102. 8.17.5 Ocumedic, Inc. Recent Developments
  103. 8.18 Owen Mumford
  104. 8.18.1 Owen Mumford Company Information
  105. 8.18.2 Owen Mumford Business Overview
  106. 8.18.3 Owen Mumford Ophthalmic Drug Delivery System Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Owen Mumford Ophthalmic Drug Delivery System Product Portfolio
  108. 8.18.5 Owen Mumford Recent Developments
  109. 8.19 Re-Vana Therapeutics
  110. 8.19.1 Re-Vana Therapeutics Company Information
  111. 8.19.2 Re-Vana Therapeutics Business Overview
  112. 8.19.3 Re-Vana Therapeutics Ophthalmic Drug Delivery System Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Re-Vana Therapeutics Ophthalmic Drug Delivery System Product Portfolio
  114. 8.19.5 Re-Vana Therapeutics Recent Developments
  115. 8.20 Santen Pharmaceutical
  116. 8.20.1 Santen Pharmaceutical Company Information
  117. 8.20.2 Santen Pharmaceutical Business Overview
  118. 8.20.3 Santen Pharmaceutical Ophthalmic Drug Delivery System Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Santen Pharmaceutical Ophthalmic Drug Delivery System Product Portfolio
  120. 8.20.5 Santen Pharmaceutical Recent Developments
  121. 8.21 Silgan Holdings Inc.
  122. 8.21.1 Silgan Holdings Inc. Company Information
  123. 8.21.2 Silgan Holdings Inc. Business Overview
  124. 8.21.3 Silgan Holdings Inc. Ophthalmic Drug Delivery System Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Silgan Holdings Inc. Ophthalmic Drug Delivery System Product Portfolio
  126. 8.21.5 Silgan Holdings Inc. Recent Developments
  127. 8.22 Taiwan Liposome
  128. 8.22.1 Taiwan Liposome Company Information
  129. 8.22.2 Taiwan Liposome Business Overview
  130. 8.22.3 Taiwan Liposome Ophthalmic Drug Delivery System Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Taiwan Liposome Ophthalmic Drug Delivery System Product Portfolio
  132. 8.22.5 Taiwan Liposome Recent Developments
  133. 8.23 Terumo Corporation
  134. 8.23.1 Terumo Corporation Company Information
  135. 8.23.2 Terumo Corporation Business Overview
  136. 8.23.3 Terumo Corporation Ophthalmic Drug Delivery System Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Terumo Corporation Ophthalmic Drug Delivery System Product Portfolio
  138. 8.23.5 Terumo Corporation Recent Developments
  139. 8.24 West Pharmaceutical Services, Inc.
  140. 8.24.1 West Pharmaceutical Services, Inc. Company Information
  141. 8.24.2 West Pharmaceutical Services, Inc. Business Overview
  142. 8.24.3 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Product Portfolio
  144. 8.24.5 West Pharmaceutical Services, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ophthalmic Drug Delivery System Value Chain Analysis
  2. 9.1.1 Ophthalmic Drug Delivery System Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ophthalmic Drug Delivery System Sales Mode & Process
  6. 9.2 Ophthalmic Drug Delivery System Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ophthalmic Drug Delivery System Distributors
  9. 9.2.3 Ophthalmic Drug Delivery System Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst